Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24

Park, Jinsung; Shin, Dong Wook; Kim, Tae-Hwan; Jung, Seung Il; Nam, Jong Kil; Park, Seung Chol; Hong, Sungwoo; Jung, Jae Hung; Kim, Hongwook; Kim, Won Tae

Patients who underwent TURBT with curative intent for primary or recurrent bladder tumor were prospectively recruited from November 2014 and December 2015 at nine university hospitals, with follow-up data collected through July 2016. Inclusion criteria were patients who underwent TURBT for histologically confirmed NMIBC. Exclusion criteria were (1) muscle-invasive BC, (2) history of previous upper urinary tract cancer, (3) patients with prior or concurrent malignancies in other organs, and (4) patients who have difficulties in communicating with clinician. No age limit was imposed. Institutional Review Board of each participating center approved the study protocol, and all study subjects were fully informed about the purpose of the study and provided written consent for their participation.